0001576280-22-000029.txt : 20220511
0001576280-22-000029.hdr.sgml : 20220511
20220511205415
ACCESSION NUMBER: 0001576280-22-000029
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220501
FILED AS OF DATE: 20220511
DATE AS OF CHANGE: 20220511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalia Kumud
CENTRAL INDEX KEY: 0001927831
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 22915356
MAIL ADDRESS:
STREET 1: 505 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 3000 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
3
1
wf-form3_165231683923225.xml
FORM 3
X0206
3
2022-05-01
0
0001576280
Guardant Health, Inc.
GH
0001927831
Kalia Kumud
505 PENOBSCOT DR
REDWOOD CITY
CA
94063
0
1
0
0
Chief Information Officer
COMMON STOCK
20530
D
RESTRICTED STOCK UNITS
0.0
COMMON STOCK
41747.0
D
STOCK OPTION (RIGHT TO BUY)
117.61
2031-11-01
COMMON STOCK
22726.0
D
STOCK OPTION (RIGHT TO BUY)
74.0
2030-04-20
COMMON STOCK
28670.0
D
(1)The Restricted Stock Units consist of three grants totaling 41,747 shares outstanding as of May 1, 2022. The first grant was granted on April 20, 2020, of which 10,751 shares are outstanding and vests 25% annually commencing on January 7, 2020. The second grant was granted on September 11, 2020, of which 19,633 shares are outstanding and vests 25% annually commencing on September 9, 2020. The third grant was granted on November 2, 2021, of which 11,363 shares are outstanding, and vests 25% on the first anniversary and quarterly thereafter commencing on September 1, 2021.
Not applicable to Restricted Stock Units.
The stock option vests and becomes exercisable as to 25% of the shares on September 1, 2022, and then in equal monthly installments through September 1, 2025.
The stock option vests and becomes exercisable as to 25% of the shares on January 7, 2021, and then in equal monthly installments through January 7, 2024.
John Saia
2022-05-11